https://www.pharmanow.live/latest-news/hepion-pharmaceuticals-fda-gv104-gambling-disorder-505b2-pathway 2026-10-19T21:58:20+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Hepion Pharmaceuticals Gains FDA Clarity on GV104 Pathway for Gambling Disorder Hepion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://app.accessnewswire.com/img.ashx?id=1238047 https://www.pharmanow.live/latest-news/fda-pediatric-advisory-committee-september-2026-meeting-materials-biologics 2026-10-19T21:59:41+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 FDA Pediatric Advisory Committee Releases September 2026 Meeting Materials for Biologics Review FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/93c14ad5-a8d4-4ad5-b04a-542d727235e1/2933cc23-97fe-461f-a22a-280326f7c213.png https://www.pharmanow.live/latest-news/dogwood-therapeutics-secures-5-million-ck-life-sciences-halneuron-phase-3-preparation 2026-10-19T21:59:04+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Dogwood Therapeutics Secures $5 Million from CK Life Sciences to Fund Halneuron Phase 3 Preparation Dogwood https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/93c14ad5-a8d4-4ad5-b04a-542d727235e1/124b4f4a-5869-4f89-acde-59f02201599f.png https://www.pharmanow.live/latest-news/cormica-surrogate-molecule-hplc-dual-detection-potent-compound-classification 2026-10-19T21:57:25+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Cormica Develops Dual-Detection HPLC Method for Potent API Classification Cormica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/06/Naproxen-Article-Banner-Image-600x200.png https://www.pharmanow.live/latest-news/insmed-launches-brinsupri-japan-mhlw-approval-ncfb 2026-10-19T21:53:53+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Insmed Launches BRINSUPRI in Japan for NCFB Treatment Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a02a12b5-6dfe-4ae7-aafe-97d8580c317f/649ce3ef-9588-4e4d-bd33-addf0467937f.png https://www.pharmanow.live/latest-news/abbvie-abbv-466-dual-targeting-phase-2a-crohns-endoscopic-remission 2026-10-19T21:52:42+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 AbbVie’s ABBV-466 Achieves 40.5% Endoscopic Remission in Crohn’s Trial AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a02a12b5-6dfe-4ae7-aafe-97d8580c317f/865b002c-f53f-4b2b-88e1-738f3970d06e.png https://www.pharmanow.live/latest-news/thermo-fisher-cphi-milan-2026 2026-10-19T15:48:41+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Thermo Fisher CPHI Milan 2026: Drug Development Expansion Thermo Fisher CPHI Milan 2026, Thermo Fisher drug development, OSD Express, Steriles Express Solutions, KinetiSol Technology, AustinPx, sterile manufacturing https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/thermo-fisher-cphi-milan-202620261019154441.webp https://www.pharmanow.live/latest-news/telix-ekalia-astatine-211-production-us-rls-network 2026-10-19T21:49:53+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Telix and Ekalia Sign Collaboration to Scale Astatine-211 Production Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/550537c8-7b6f-479a-a139-fe52ad866159/46462c71-d509-4902-a0e9-5c169dcadf96.png